These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


399 related items for PubMed ID: 27693733

  • 21. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro.
    Horn G, de Koning MC, van Grol M, Thiermann H, Worek F.
    Toxicol Lett; 2018 Dec 15; 299():218-225. PubMed ID: 30312685
    [Abstract] [Full Text] [Related]

  • 22. Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands.
    Gašo Sokač D, Zandona A, Roca S, Vikić-Topić D, Lihtar G, Maraković N, Bušić V, Kovarik Z, Katalinić M.
    Int J Mol Sci; 2022 Nov 02; 23(21):. PubMed ID: 36362178
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and evaluation of novel analogues of vitamin B6 as reactivators of tabun and paraoxon inhibited acetylcholinesterase.
    Gaso-Sokac D, Katalinić M, Kovarik Z, Busić V, Kovac S.
    Chem Biol Interact; 2010 Sep 06; 187(1-3):234-7. PubMed ID: 20144593
    [Abstract] [Full Text] [Related]

  • 24. Reactivation of organophosphate-inhibited human acetylcholinesterase by isonitrosoacetone (MINA): a kinetic analysis.
    Worek F, Thiermann H.
    Chem Biol Interact; 2011 Nov 15; 194(2-3):91-6. PubMed ID: 21930118
    [Abstract] [Full Text] [Related]

  • 25. Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents.
    Zorbaz T, Malinak D, Hofmanova T, Maraković N, Žunec S, Hrvat NM, Andrys R, Psotka M, Zandona A, Svobodova J, Prchal L, Fingler S, Katalinić M, Kovarik Z, Musilek K.
    Eur J Med Chem; 2022 Aug 05; 238():114377. PubMed ID: 35526478
    [Abstract] [Full Text] [Related]

  • 26. Quantum chemical and steered molecular dynamics studies for one pot solution to reactivate aged acetylcholinesterase with alkylator oxime.
    Chandar NB, Lo R, Ganguly B.
    Chem Biol Interact; 2014 Nov 05; 223():58-68. PubMed ID: 25218671
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A, Calić M, Radić B, Berend S, Jun D, Kuca K, Kovarik Z.
    Toxicology; 2006 Nov 10; 228(1):41-50. PubMed ID: 16982122
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase.
    Horn G, Wille T, Musilek K, Kuca K, Thiermann H, Worek F.
    Arch Toxicol; 2015 Mar 10; 89(3):405-14. PubMed ID: 24912784
    [Abstract] [Full Text] [Related]

  • 37. Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents.
    Renou J, Mercey G, Verdelet T, Păunescu E, Gillon E, Arboléas M, Loiodice M, Kliachyna M, Baati R, Nachon F, Jean L, Renard PY.
    Chem Biol Interact; 2013 Mar 25; 203(1):81-4. PubMed ID: 23111374
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.